Literature DB >> 31189177

Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.

Phuc L H Vo1, Tyler S Halpin-Healy2, Sanne E Klompe2, Samuel H Sternberg3.   

Abstract

Conventional CRISPR-Cas systems maintain genomic integrity by leveraging guide RNAs for the nuclease-dependent degradation of mobile genetic elements, including plasmids and viruses. Here we describe a notable inversion of this paradigm, in which bacterial Tn7-like transposons have co-opted nuclease-deficient CRISPR-Cas systems to catalyse RNA-guided integration of mobile genetic elements into the genome. Programmable transposition of Vibrio cholerae Tn6677 in Escherichia coli requires CRISPR- and transposon-associated molecular machineries, including a co-complex between the DNA-targeting complex Cascade and the transposition protein TniQ. Integration of donor DNA occurs in one of two possible orientations at a fixed distance downstream of target DNA sequences, and can accommodate variable length genetic payloads. Deep-sequencing experiments reveal highly specific, genome-wide DNA insertion across dozens of unique target sites. This discovery of a fully programmable, RNA-guided integrase lays the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed repair.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31189177     DOI: 10.1038/s41586-019-1323-z

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  2 in total

1.  Gain-of-function mutations in TnsC, an ATP-dependent transposition protein that activates the bacterial transposon Tn7.

Authors:  A E Stellwagen; N L Craig
Journal:  Genetics       Date:  1997-03       Impact factor: 4.562

2.  The CRISPR RNA-guided surveillance complex in Escherichia coli accommodates extended RNA spacers.

Authors:  Michelle L Luo; Ryan N Jackson; Steven R Denny; Monika Tokmina-Lukaszewska; Kenneth R Maksimchuk; Wayne Lin; Brian Bothner; Blake Wiedenheft; Chase L Beisel
Journal:  Nucleic Acids Res       Date:  2016-05-12       Impact factor: 16.971

  2 in total
  117 in total

1.  CRISPR, animals, and FDA oversight: Building a path to success.

Authors:  Laura R Epstein; Stella S Lee; Mayumi F Miller; Heather A Lombardi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-30       Impact factor: 11.205

2.  CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.

Authors:  Nirakar Sahoo; Victoria Cuello; Shreya Udawant; Carl Litif; Julie A Mustard; Megan Keniry
Journal:  Methods Mol Biol       Date:  2020

3.  CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering.

Authors:  Phuc Leo H Vo; Carlotta Ronda; Sanne E Klompe; Ethan E Chen; Christopher Acree; Harris H Wang; Samuel H Sternberg
Journal:  Nat Biotechnol       Date:  2020-11-23       Impact factor: 54.908

Review 4.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

5.  CRISPR Surveillance Turns Transposon Taxi.

Authors:  Tanner Wiegand; Blake Wiedenheft
Journal:  CRISPR J       Date:  2020-02

6.  An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions.

Authors:  Sway P Chen; Harris H Wang
Journal:  CRISPR J       Date:  2019-11-19

Review 7.  Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

8.  Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.

Authors:  Geoffrey L Rogers; Hsu-Yu Chen; Heidy Morales; Paula M Cannon
Journal:  Mol Ther       Date:  2019-09-09       Impact factor: 11.454

9.  Diverse enzymatic activities mediate antiviral immunity in prokaryotes.

Authors:  Linyi Gao; Han Altae-Tran; Francisca Böhning; Kira S Makarova; Michael Segel; Jonathan L Schmid-Burgk; Jeremy Koob; Yuri I Wolf; Eugene V Koonin; Feng Zhang
Journal:  Science       Date:  2020-08-28       Impact factor: 47.728

Review 10.  Targeted transposition with Tn7 elements: safe sites, mobile plasmids, CRISPR/Cas and beyond.

Authors:  Joseph E Peters
Journal:  Mol Microbiol       Date:  2019-09-18       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.